STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1111 by analyst upside · 2026-08-14
KOD
Kodiak Sciences Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+62.6%
implied upside to consensus target
Current Price $39.98
Consensus Target $65.0
Bull Target $80.0
Bear Target $56.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $8.29
52-Week High $47.84
YTD Return +53.7%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-4.17
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $8.29
52-Week High $47.84
Current Price $39.98
Bear Target $56.0
Bull Target $80.0
● Now $39.98 ● Target $65.0
TRADING DATA
Avg Volume 709K
YTD Return +53.7%
Analyst Count 5
Consensus Buy
Upside to Target +62.6%
Last Updated 2026-08-14

ANALYST SUMMARY

Kodiak Sciences Inc. (KOD) is currently trading at $39.98 with a Wall Street consensus price target of $65.0, implying potential upside of 62.6% over the next 12 months. 5 analysts currently cover KOD, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $80.0, while the most cautious has a target of $56.0.

KOD operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 53.7% year-to-date and is currently trading near the upper end of its 52-week range of $8.29 – $47.84.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for KOD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Chardan Capital ↑ Upgrade
Neutral → Buy 2026-05-11 33% win rate (6 calls)
UBS - Reiterated
Buy → Buy 2026-03-27 33% win rate (6 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-03-27 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-02-10 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-01-22 31% win rate (48 calls)
UBS ● Initiated
Buy 2026-01-07 33% win rate (6 calls)
Chardan Capital - Reiterated
Neutral → Neutral 2025-11-17 33% win rate (6 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-11-17 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
59
out of 100
Coverage depth
14/30
Consensus clarity
18/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →